# Partial Liver Segment 2/3 Transplantation Study

Source: https://onco.cc/trials/nct02215889/  
OnCo record `nct02215889` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial in colorectal cancer, run by Oslo University Hospital, now recruiting.

## Summary

Partial Liver Segment 2/3 Transplantation Study is a phase 1/2, interventional study registered as NCT02215889 by Oslo University Hospital, with a registry enrolment figure of 20 participants, started 2014-06 and due to reach its primary completion in 2025-06. Interventions recorded: Liver transplantation. Conditions listed: Colorectal Cancer. Primary outcome: Percent of transplanted patients receiving second stage hepatectomy within 4 weeks of segment 2/3 transplantation.. Colorectal eligibility wording from the registry: "* Histologically verified adenocarcinoma in colon/rectum". Sites: Norway. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT02215889
- Phase: 1/2
- Setting: A Phase I/II Clinical Trial to Evaluate the Benefit and Efficacy of Liver Resection And Partial Liver Segment 2/3 Transplantation With Delayed Total Hepatectomy as Treatment for Selected Patients With Liver Metastases From ColoRectal Carcinoma
- Sponsor: Oslo University Hospital
- Enrolled: 20

## Sources

- ClinicalTrials.gov NCT02215889: https://clinicaltrials.gov/study/NCT02215889

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct02215889.json